Newark-based Biopharma institute publishes tech roadmaps

201
University of Delaware photo.
Advertisement

The Newark-based  National Institute for Innovation in Manufacturing Biopharmaceuticals announced the publication of three technology roadmaps designed to benefit the biopharmaceutical community.

The three roadmaps focus on manufacturing issues involving: Gene Therapy,  Vaccines, and   Antibody-Drug Conjugates and Bi-specific Antibodies.

NIIMBL convened experts from manufacturers, equipment makers, suppliers, academic institutions, non-profits, and federal agencies. More than 40 organizations, including NIIMBL members and non-members, contributed to the effort.

“Through these roadmaps, we set out to create a clear vision of innovation for biopharmaceutical manufacturing processes and platforms that will, ultimately, enhance access to the medicines that have the ability to improve and save lives. We are grateful to all of those who contributed their time, energy, and talent to this process,” said Kelvin Lee, NIIMBL Institute director.

The NIIMBL roadmaps can be downloaded at http://www.niimbl.org.

Advertisement

  NIIMBL will begin work on its next set of roadmaps addressing additional topics of interest to the biopharmaceutical community.

NIIMBL is a public-private partnership with the goal of advancing innovation in biopharmaceutical manufacturing.

NIIMBL is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce and leverages additional support from industry, academic institutions, non-profit organizations, and the states of Delaware, Maryland, North Carolina, and the Commonwealth of Massachusetts.

The NIIMBL mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce.

NIIMBL is based in Newark, with a headquarters under construction on the University of Delaware STAR Campus, the former Chrysler site.

Advertisement
Advertisement